tm logo
INPEFA. SOTAGLIFLOZIN TABLETS
Live/Registered
REGISTERED

on 15 Aug 2023

Last Applicant/ Owned by

2445 Technology Forest Blvd., Suite 1100

The Woodlands

TX

77381

Serial Number

97653516 filed on 28th Oct 2022

Registration Number

7141092 registered on 15th Aug 2023

in the Principal Register

Correspondent Address

W. Scott Brown

VINSON & ELKINS LLP

845 TEXAS AVENUE, SUITE 4700

HOUSTON, TX 77002

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"TABLETS"

INPEFA. SOTAGLIFLOZIN TABLETS

"TABLETS" Color is not claimed as a feature of the mark. Pharmaceutical preparations for the treatment or prevention of heart failure The mark consists of stlylized phrase "inpefa. sotagliflozin tablets".

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment or prevention of heart failure


First Use Date in General

18th May 2023

First Use Date in Commerce

18th May 2023

Mark Details


Serial Number

No 97653516

Mark Type

No Service/Collective Mark

Attorney Docket Number

No LEX350

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of stlylized phrase "inpefa. sotagliflozin tablets".

Legal History


Show more

Status DateAction Taken
15th Aug 2023REGISTERED-PRINCIPAL REGISTER
15th Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
11th Jul 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10th Jul 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17th Jun 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Jun 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
16th Jun 2023SOU EXTENSION 1 GRANTED
16th Jun 2023STATEMENT OF USE PROCESSING COMPLETE
08th Jun 2023TEAS STATEMENT OF USE RECEIVED
08th Jun 2023SOU TEAS EXTENSION RECEIVED